Home >> Company >> Board

Stuart Berman, Chairman
Mr. Berman brings with him more than 20 years of wide-ranging management experience. Since 2000 he has served as a Trustee of the Barnet Segal Charitable Trust. Prior to that he held management and executive positions with Silicon Valley technology companies ranging in size from start-ups such as Lightning Software to world-renowned compa
Christian V. Olgaard, Lead Investor and Independent Director
Christian V Olgaard is CTO at LitePoint – a company he co-founded in 2000. Teradyne acquired LitePoint In 2011. Prior to founding LitePoint he worked at National Semiconductor working on wireless IC technology. He holds many patents and has rich experience in patent generation and patent strategy. Christian is an angel investor and
Winnie Wan, Independent Director
Winnie Wan, Ph.D. is an industry veteran, with extensive experience in launching and building diagnostic and therapeutic businesses with start-ups and within large corporations in the last 30 years. She has successfully commercialized disruptive technologies from inception. These technologies include the analytical systems for drug develo
Ken Harris, President & Chief Executive Officer
Ken serves as the President and Chief Executive Officer of Bell BioSystems, and has previously served on the Boards of Cesca Therapeutics (Nasdaq: KOOL), TotipotentRX Corporation, MK Alliance, Inc., TotipotentSC Scientific Product Pvt. Ltd. (India Corporation).
Caleb B. Bell III, Chief Technology Officer & Co-Founder
Caleb served as CEO of Bell Biosystems since co-founding through June 2017 when he assumed full time technical leadership of the company as CTO.  Under Caleb’s leadership, Bell Biosystems has been recognized by the White House for its “Breakthrough” in life science technologies, as a 2014 Rising Star by BayBio, and
Contact Us Sitemap Terms of Use
Follow Bell Biosystems
© 2017 Bell Biosystems. All rights are reserved
Website Security Test